Skip to content

Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil

Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil After Randomized, Double-blind, Placebo-controlled Oral Administration

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02110732
Enrollment
40
Registered
2014-04-10
Start date
2011-01-31
Completion date
2011-05-31
Last updated
2021-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Respiratory Infection, Acute Otitis Media

Brief summary

The purpose of this study is to evaluate the effect of oral administration of probiotic Lactobacillus rhamnosus GG in middle ear and adenoid tonsil.

Interventions

DIETARY_SUPPLEMENTLactobacillus rhamnosus GG

Sponsors

Finnish Institute for Health and Welfare
CollaboratorOTHER_GOV
Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Years to 5 Years
Healthy volunteers
Yes

Inclusion criteria

* recurrent otitis media * secretory otitis media * chronic rhinitis * recurrent sinusitis

Exclusion criteria

* significant illness

Design outcomes

Primary

MeasureTime frameDescription
Lactobacillus Rhamnosus GG in Middle Ear Effusion and Adenoid TonsilAfter 3 weeks of oral consumptionPresence of Lactobacillus rhamnosus GG in middle ear effusion of children having tympanostomy after oral administration of L. GG.

Secondary

MeasureTime frameDescription
Presence of Bacterial Pathogens in Middle Ear Effusion SamplesAfter 3 weeks of oral consumptionAssociation of Lactobacillus rhamnosus GG with occurrence of bacterial pathogens in the middle ear.
Presence of Rhinovirus and Enterovirus in Middle Ear Effusion SamplesAfter 3 weeks of oral consumptionAssociation of Lactobacillus rhamnosus GG with occurrence of viral pathogens in the middle ear.

Participant flow

Participants by arm

ArmCount
Lactobacillus Rhamnosus GG
Lactobacillus rhamnosus GG 8-9 x 10 -9 pmy 2x2 for 3 weeks Lactobacillus rhamnosus GG
20
Crystalline Cellulose
Crystalline cellulose Lactobacillus rhamnosus GG
20
Total40

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up11
Overall StudyPhysician Decision52

Baseline characteristics

CharacteristicCrystalline CelluloseTotalLactobacillus Rhamnosus GG
Age, Categorical
<=18 years
20 Participants40 Participants20 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Finland
20 Participants40 Participants20 Participants
Sex: Female, Male
Female
9 Participants17 Participants8 Participants
Sex: Female, Male
Male
11 Participants23 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Lactobacillus Rhamnosus GG in Middle Ear Effusion and Adenoid Tonsil

Presence of Lactobacillus rhamnosus GG in middle ear effusion of children having tympanostomy after oral administration of L. GG.

Time frame: After 3 weeks of oral consumption

Population: Number of participants with tympanostomy

ArmMeasureValue (COUNT_OF_UNITS)
Lactobacillus Rhamnosus GGLactobacillus Rhamnosus GG in Middle Ear Effusion and Adenoid Tonsil4 Samples
Crystalline CelluloseLactobacillus Rhamnosus GG in Middle Ear Effusion and Adenoid Tonsil1 Samples
p-value: 0.05Fisher Exact
Secondary

Presence of Bacterial Pathogens in Middle Ear Effusion Samples

Association of Lactobacillus rhamnosus GG with occurrence of bacterial pathogens in the middle ear.

Time frame: After 3 weeks of oral consumption

Population: Number of participants with tympanostomy

ArmMeasureValue (COUNT_OF_UNITS)
Lactobacillus Rhamnosus GGPresence of Bacterial Pathogens in Middle Ear Effusion Samples12 Samples
Crystalline CellulosePresence of Bacterial Pathogens in Middle Ear Effusion Samples3 Samples
p-value: <0.05Chi-squared
Secondary

Presence of Rhinovirus and Enterovirus in Middle Ear Effusion Samples

Association of Lactobacillus rhamnosus GG with occurrence of viral pathogens in the middle ear.

Time frame: After 3 weeks of oral consumption

Population: Number of participants with tympanostomy

ArmMeasureValue (COUNT_OF_UNITS)
Lactobacillus Rhamnosus GGPresence of Rhinovirus and Enterovirus in Middle Ear Effusion Samples11 Samples
Crystalline CellulosePresence of Rhinovirus and Enterovirus in Middle Ear Effusion Samples1 Samples
p-value: <0.05Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026